LAYNIE MASON: Open Payments
NPI 1790391571 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$220 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $184 · 2025 $220
Food & beverage: $220
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $51 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| Verona Pharma, Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Grifols USA, LLC | 1 | $21 |
| United Therapeutics Corporation | 1 | $18 |
| Viatris Specialty LLC | 1 | $16 |
Products named: TRELEGY ELLIPTA, TEZSPIRE, WINREVAIR, Ohtuvayre, DUPIXENT, Prolastin-C Liquid, Tyvaso, ZERBAXA.
Industry payments across IN — which companies pay providers there.
